675 related articles for article (PubMed ID: 23383562)
1. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.
Creinin MD; Vittinghoff E; Keder L; Darney PD; Tiller G
Contraception; 1996 Jun; 53(6):321-7. PubMed ID: 8773418
[TBL] [Abstract][Full Text] [Related]
3. Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.
Schreiber CA; Creinin MD; Atrio J; Sonalkar S; Ratcliffe SJ; Barnhart KT
N Engl J Med; 2018 Jun; 378(23):2161-2170. PubMed ID: 29874535
[TBL] [Abstract][Full Text] [Related]
4. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
[TBL] [Abstract][Full Text] [Related]
5. Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac.
Reeves MF; Kudva A; Creinin MD
Contraception; 2008 Oct; 78(4):332-5. PubMed ID: 18847584
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
7. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
[TBL] [Abstract][Full Text] [Related]
8. Mifepristone and misoprostol for early abortion when no gestational sac is present.
Schaff EA; Fielding SL; Eisinger S; Stadalius L
Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
[TBL] [Abstract][Full Text] [Related]
9. Simplified medical abortion screening: a demonstration project.
Raymond EG; Tan YL; Comendant R; Sagaidac I; Hodorogea S; Grant M; Sanhueza P; Van Pratt E; Gillespie G; Boraas C; Weaver MA; Platais I; Bousieguez M; Winikoff B
Contraception; 2018 Apr; 97(4):292-296. PubMed ID: 29170088
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for first-trimester pregnancy failure.
Gilles JM; Creinin MD; Barnhart K; Westhoff C; Frederick MM; Zhang J;
Am J Obstet Gynecol; 2004 Feb; 190(2):389-94. PubMed ID: 14981379
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion.
Creinin MD; Carbonell JL; Schwartz JL; Varela L; Tanda R
Contraception; 1999 Jan; 59(1):11-6. PubMed ID: 10342081
[TBL] [Abstract][Full Text] [Related]
12. Misoprostol to treat missed abortion in the first trimester.
Gemzell-Danielsson K; Ho PC; Gómez Ponce de León R; Weeks A; Winikoff B
Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S182-5. PubMed ID: 17961567
[TBL] [Abstract][Full Text] [Related]
13. Endometrial thickness after misoprostol use for early pregnancy failure.
Creinin MD; Harwood B; Guido RS; Fox MC; Zhang J;
Int J Gynaecol Obstet; 2004 Jul; 86(1):22-6. PubMed ID: 15207665
[TBL] [Abstract][Full Text] [Related]
14. Misoprostol-induced termination of second-trimester pregnancy in women with a history of cesarean section: a retrospective analysis of 56 cases.
Turgut A; Ozler A; Görük NY; Karaçor T; Yalinkaya A
Ginekol Pol; 2013 Apr; 84(4):277-80. PubMed ID: 23700860
[TBL] [Abstract][Full Text] [Related]
15. Sublingual versus vaginal misoprostol for cervical dilatation 1 or 3 h prior to surgical abortion: a double-blinded RCT.
Sääv I; Kopp Kallner H; Fiala C; Gemzell-Danielsson K
Hum Reprod; 2015 Jun; 30(6):1314-22. PubMed ID: 25840429
[TBL] [Abstract][Full Text] [Related]
16. Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
Arch Gynecol Obstet; 2020 Nov; 302(5):1279-1296. PubMed ID: 32638095
[TBL] [Abstract][Full Text] [Related]
17. Sublingual versus vaginal misoprostol for the management of missed abortion.
Tanha FD; Feizi M; Shariat M
J Obstet Gynaecol Res; 2010 Jun; 36(3):525-32. PubMed ID: 20598032
[TBL] [Abstract][Full Text] [Related]
18. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
Singh K; Fong YF; Dong F
BJOG; 2003 Feb; 110(2):175-80. PubMed ID: 12618162
[TBL] [Abstract][Full Text] [Related]
19. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
[TBL] [Abstract][Full Text] [Related]
20. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol.
Jain JK; Meckstroth KR; Mishell DR
Am J Obstet Gynecol; 1999 Dec; 181(6):1386-91. PubMed ID: 10601917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
